The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

Amethyst 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on Amethyst 28 Day availability issues in 2026 — including therapeutic substitutions, patient counseling, and workflow solutions.

Analpram HC Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Analpram HC availability in 2026: formulary status, prescribing alternatives, and how to help patients navigate pharmacy stockouts.

Anastrozole Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists, OB-GYNs, and PCPs on anastrozole supply challenges in 2026 — including substitution guidance, patient communication, and proactive strategies.

Anusol HC Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Anusol HC availability, therapeutic substitutes, and how to help patients navigate prescription filling challenges in 2026.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Apidra Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Apidra (insulin glulisine) supply and availability in 2026 — what prescribers need to know about stock gaps, alternatives, and patient resources.

Arazlo Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for dermatologists and prescribers on Arazlo availability in 2026 — covering supply gaps, prescribing considerations, and patient access tools.

Arimidex Shortage: What Providers and Prescribers Need to Know in 2026
Clinicians managing breast cancer patients on anastrozole need current information on availability, clinical alternatives, and patient communication strategies for 2026.

Atogepant Shortage: What Providers and Prescribers Need to Know in 2026
A 2026 clinical guide for providers on atogepant (Qulipta) availability, PA requirements, formulary barriers, and patient access strategies.

Bactroban Shortage: What Providers and Prescribers Need to Know in 2026
No active FDA shortage exists for Bactroban in 2026, but providers should understand local availability gaps, resistance trends, and when to switch.

Besivance Availability: What Providers and Prescribers Need to Know in 2026
A clinical briefing for ophthalmologists, optometrists, and prescribers on Besivance (besifloxacin) availability, insurance barriers, and alternative management strategies in 2026.

Betamethasone Shortage: What Providers and Prescribers Need to Know in 2026
Betamethasone is not in a national shortage, but providers are seeing access issues linked to formulation fragmentation and spill-over demand. Here's the clinical picture for 2026.

Brenzavvy (Bexagliflozin) Shortage: What Providers and Prescribers Need to Know in 2026
Brenzavvy (bexagliflozin) is clinically effective and highly affordable — but its distribution model creates prescription access challenges. Here's what prescribers need to know in 2026.